ESR1 and breast ductal adenocarcinoma: Among those drugs we also identified two cardiac glycosides (CGs), i.e., ouabain-OU and digoxin-Digo [20], as compounds that potentially reduce ERα levels, and prevent cell proliferation in ductal carcinoma cells (MCF-7 cells) [18].